Spyre Therapeutics Stock Up 565% in a Year, But Momentum Now Fades Near Highs

Spyre Therapeutics stock remains one of the more explosive biotech stories of the past year. The stock surged roughly 565% over twelve months and touched a fresh three-year high. On Tuesday, SYRE closed at 107.36, down from an intraday high of 110.15. The pullback is modest, but momentum is cooling.

Key takeaways

• SYRE closed Tuesday at 107.36, down from an intraday high of 110.15, after a roughly 565% twelve-month surge.
• The daily trend remains bullish with price above the EMA20 at 104.09, EMA50 at 96.81, and EMA200 at 66.64.
• The daily MACD shows a negative histogram of -0.14, indicating that upside thrust has softened.
• Daily ATR14 sits at 4.75, and short interest is 13.81% of float, supporting elevated two-sided risk.
• The bullish scenario requires reclaiming the daily pivot at 108.15, with resistance at 109.36.

Spyre Therapeutics Stock Daily Trend: Structure Still Favors the Bulls

The daily trend for Spyre Therapeutics stock still favors the bulls. Price trades well above the EMA20 at 104.09, the EMA50 at 96.81, and the EMA200 at 66.64. That stacked alignment is a textbook bullish structure. It confirms the primary trend since last year has not been broken. The daily regime reading is also labeled bullish, matching the price action.

… Continue reading the full article at the original source below.